Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Montréal

$15,000.00

Development and adaptation of mathematical methodologies for drug evaluation and use

EF 2014-15

Résumé
Model-based drug research and development is now promulgated by regular authorities as an important approach that substantially contributes to drug management and decision-making. The same vision has been embraced by academia through launching of several fundamental research activities and specialized curricula. We observe that drug-related research has been progressively evolving towards an exact science discipline that can benefit from great mathematical inspiration and interest. The objective of the present research program is to build a solid theoretical framework for drug development and evaluation by introducing appropriate mathematical methodologies. This direction in our research simply echoes the increasing need for more accurate metrics for therapeutic evaluation and prediction. It is undeniable that the deterministic mathematical representation based on differential equations has brought great insights to the biopharmaceutical field and traced the path towards its quantitative era. However, the increasingly reported variability, supported by newly acquired data through advanced measurement techniques, along with the progress in drug-related knowledge, challenges this deterministic vision for many aspects of the field. Since this variability is not generally included into traditional metrics, and because of the increasingly reported evidence for its impact, proposition of theoretically-based pharmacological metrics becomes an unavoidable step in order to provide a fair evaluation of drug performance and reduce consequences of inappropriate drug use. The probabilistic features, which undoubtedly are intrinsic part of this variability, should be allocated a sufficient weight for this new investigation. Using various mathematical approaches, we will work at different levels that contribute to therapeutic variability, going from the drug intake, to drug absorption and disposition within the body and then to drug action.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
227118-2010
Name nom
Nekka, Fahima
Department département
Pharmacie, faculté de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
15000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2950
Research subject group en
Applied mathematics
Research subject group fr
Mathématiques appliquées
Research subject en
Applied mathematics
Research subject fr
Mathématiques appliquées
Partie
5
Nb partie
5
Application title
Development and adaptation of mathematical methodologies for drug evaluation and use
Keyword
NSERC
Application summary
Model-based drug research and development is now promulgated by regular authorities as an important approach that substantially contributes to drug management and decision-making. The same vision has been embraced by academia through launching of several fundamental research activities and specialized curricula. We observe that drug-related research has been progressively evolving towards an exact science discipline that can benefit from great mathematical inspiration and interest. The objective of the present research program is to build a solid theoretical framework for drug development and evaluation by introducing appropriate mathematical methodologies. This direction in our research simply echoes the increasing need for more accurate metrics for therapeutic evaluation and prediction. It is undeniable that the deterministic mathematical representation based on differential equations has brought great insights to the biopharmaceutical field and traced the path towards its quantitative era. However, the increasingly reported variability, supported by newly acquired data through advanced measurement techniques, along with the progress in drug-related knowledge, challenges this deterministic vision for many aspects of the field. Since this variability is not generally included into traditional metrics, and because of the increasingly reported evidence for its impact, proposition of theoretically-based pharmacological metrics becomes an unavoidable step in order to provide a fair evaluation of drug performance and reduce consequences of inappropriate drug use. The probabilistic features, which undoubtedly are intrinsic part of this variability, should be allocated a sufficient weight for this new investigation. Using various mathematical approaches, we will work at different levels that contribute to therapeutic variability, going from the drug intake, to drug absorption and disposition within the body and then to drug action.